Article
Expression of CCR2, CCR5, and CXCR3 by CD4+ T cells is stable during a 2-year longitudinal study but varies widely between individuals.
Journal of neurovirology - 1 Jun 2003
Kivisäkk Pia, Trebst Corinna, Lee Jar-Chi, Tucky Barbara H, Rudick Richard A, Campbell James J, Ransohoff Richard M
Abstract excerpt
Blockade of chemokine receptors (CKRs) has recently emerged as a possible pathway for therapeutic intervention in disease. In the present report, the expression of CCR2, CCR5, and CXCR3, associated with migration of mononuclear cells to inflamed tissue, was determined on CD4+ T cells in a 2-year...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
